# Ionis Pharmaceuticals (IONS) — Analyst Forecast

IONS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ions/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 23 | 5 | 0 | 28 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $54.00 | $82.09 | $104.00 | 11 |

Last price $44.12 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | UBS | Upgraded | Neutral → Buy | $88.00 |
| Sep 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $100.00 |
| Sep 22, 2026 | JP Morgan | Maintained | Overweight | $70.00 |
| Sep 15, 2026 | Guggenheim | Maintained | Buy | $80.00 |
| Sep 9, 2026 | Barclays | Maintained | Overweight | $85.00 |
| Sep 8, 2026 | HC Wainwright & Co. | Maintained | Buy | $100.00 |
| Sep 8, 2026 | Canaccord Genuity | Maintained | Buy | $85.00 |
| Sep 8, 2026 | BMO Capital | Maintained | Market Perform | $54.00 |
| Sep 8, 2026 | Goldman Sachs | Maintained | Neutral | $56.00 |
| Sep 8, 2026 | Morgan Stanley | Maintained | Overweight | $104.00 |
| Sep 4, 2026 | HC Wainwright & Co. | Maintained | Buy | $115.00 |
| Sep 4, 2026 | BMO Capital | Maintained | Market Perform | $61.00 |
| Sep 4, 2026 | Needham | Maintained | Buy | $86.00 |
| Aug 31, 2026 | HC Wainwright & Co. | Maintained | Buy | $115.00 |
| Aug 19, 2026 | BMO Capital | Initiated Coverage | Outperform → Market Perform | $60.00 |
| Aug 3, 2026 | JP Morgan | Maintained | Overweight | $76.00 |
| Jul 30, 2026 | HC Wainwright & Co. | Maintained | Buy | $115.00 |
| Jul 30, 2026 | Wells Fargo | Maintained | Overweight | $95.00 |
| Jul 21, 2026 | Guggenheim | Maintained | Buy | $89.00 |
| Jul 16, 2026 | Wolfe Research | Downgraded | Outperform → Peer Perform | — |

## Frequently Asked Questions

### What is the price target for IONS stock?

The average 12-month analyst price target for Ionis Pharmaceuticals (IONS) is $82.09, with a high estimate of $104.00 and a low of $54.00, across 11 analysts.

### Is IONS a buy, sell, or hold?

Analysts covering Ionis Pharmaceuticals currently average a Buy rating: 23 buy, 5 hold and 0 sell, from 28 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for IONS?

The average price target of $82.09 implies 86.06% upside from the last price of $44.12.

### What is the latest analyst rating on IONS?

On Oct 15, 2026, UBS upgraded Ionis Pharmaceuticals to Buy with a price target of $88.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).